BPC-157: Oral vs Injectable
Same peptide, different delivery. Oral targets the gut directly while injectable goes systemic. Here's how to choose the right route for your goals.
💊 Oral BPC-157
- Route
Oral capsule / sublingual - Best For
Gut healing, IBD, gastric ulcers - Typical Dose
500–1,000 mcg/day - Convenience
Easy — just swallow a capsule - Stability
Unusually acid-stable for a peptide - Systemic Effects
Lower — primarily local GI action - Typical Duration
4–8 weeks
💉 Injectable BPC-157
- Route
Subcutaneous injection - Best For
Tendons, ligaments, muscles, systemic - Typical Dose
250–500 mcg/day - Convenience
Requires reconstitution + injection - Stability
Must refrigerate after reconstitution - Systemic Effects
Higher — systemic distribution - Typical Duration
4–6 weeks
Efficacy by Target
How effective each route is for different healing goals (based on available preclinical data and community reports):
💡 Why BPC-157 Survives the Stomach
Unlike most peptides that are destroyed by gastric acid, BPC-157 was originally isolated from gastric juice — it literally evolved in acid. Studies show it maintains biological activity even after prolonged exposure to gastric conditions. This makes it one of the few peptides where oral administration is a viable option. However, oral dosing delivers the peptide primarily to the GI tract, with uncertain systemic bioavailability.
Practical Considerations
💊 Oral Protocol
- Available as capsules (arginine salt form is most common)
- Take on empty stomach for best absorption
- No reconstitution, no refrigeration (for capsules)
- Higher dose needed (500–1,000 mcg) due to limited systemic absorption
- Ideal for: people with needle phobia, those targeting gut issues specifically
💉 Injectable Protocol
- Typically comes as lyophilized powder — requires reconstitution with bacteriostatic water
- Inject subcutaneously (abdomen, near injury site, or thigh)
- Lower dose needed (250–500 mcg) due to near-complete bioavailability
- Must refrigerate after reconstitution (stable 2–4 weeks in fridge)
- Ideal for: musculoskeletal injuries, post-surgical recovery, systemic healing
⚖️ Who Should Choose What?
- Your primary issue is gut-related (IBD, leaky gut, NSAID damage, gastric ulcers)
- You dislike needles or don't want to deal with reconstitution
- You want maximum convenience (just take a capsule)
- You're traveling or don't have refrigeration access
- You're treating a specific injury (tendon, ligament, muscle)
- You want systemic healing effects
- You're comfortable with subcutaneous injections
- You want lower dosing (more cost-effective per effective dose)
Some users run oral + injectable simultaneously — oral for gut healing while injecting near a specific injury. This dual-route approach covers both local GI effects and systemic tissue repair. Just account for total daily dose from both routes.
Frequently Asked Questions
For gut issues, oral may be equally or more effective (direct delivery). For injuries, injectable is generally considered superior (systemic distribution). Choose based on your target.
Yes — BPC-157 was isolated from gastric juice and is unusually acid-stable. Animal studies confirm it retains biological activity after oral dosing.
Many users prefer injecting near the injury site, but animal studies show systemic effects from any injection site. Subcutaneous injection in the abdomen also works well for general healing.
Community protocols (not clinically validated): Injectable 250-500 mcg/day, Oral 500-1,000 mcg/day, typically for 4-6 weeks. No human dose-finding trials exist.
Yes, some users combine both routes for comprehensive healing. No known contraindication, but consider total daily dose. Neither route has established human safety data.
🛒 Recommended Products
Supplies for BPC-157 protocols
Affiliate links help support HighPeptides at no extra cost to you.
Related Resources
More BPC-157 and healing peptide info